VENLAFAXINE ALEMBIC XR venlafaxine (as hydrochloride) 225 mg modified release capsule

Land: Australië

Taal: Engels

Bron: Department of Health (Therapeutic Goods Administration)

Werkstoffen:

venlafaxine hydrochloride, Quantity: 254.7 mg (Equivalent: venlafaxine, Qty 225 mg)

Beschikbaar vanaf:

Alembic Pharmaceuticals Australia Pty Ltd

farmaceutische vorm:

Capsule, modified release

Samenstelling:

Excipient Ingredients: microcrystalline cellulose; povidone; purified talc; colloidal anhydrous silica; magnesium stearate; ethylcellulose; copovidone; carmoisine; titanium dioxide; Gelatin; propylene glycol; indigo carmine; ethanol; butan-1-ol; isopropyl alcohol; Shellac; strong ammonia solution

Toedieningsweg:

Oral

Eenheden in pakket:

28

Prescription-type:

(S4) Prescription Only Medicine

therapeutische indicaties:

Venlafaxine Extended Release Capsule is indicated for the treatment of: Major Depression, including prevention of relapse and recurrence where appropriate; Generalised Anxiety disorder; Social Anxiety Disorder; Panic Disorder, including prevention of relapse.

Product samenvatting:

Visual Identification: Pink opaque cap / pink opaque body, size '00' hard capsules having thick and thin radial circular bands on both the body and cap in blue ink.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Autorisatie-status:

Registered

Autorisatie datum:

2018-08-09